BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11448032)

  • 1. Postbinding fusion function contributed by a chimeric murine leukemia virus envelope protein.
    Nakamura H; Takeda A; Matano T
    Arch Virol; 2001; 146(5):953-61. PubMed ID: 11448032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of infectious murine leukemia virus production by Fv-4 env gene products exerting dominant negative effect on viral envelope glycoprotein.
    Takeda A; Matano T
    Microbes Infect; 2007; 9(14-15):1590-6. PubMed ID: 18023391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted infection of a retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1.
    Matano T; Odawara T; Iwamoto A; Yoshikura H
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3165-9. PubMed ID: 8847525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. trans-dominant interference with virus infection at two different stages by a mutant envelope protein of Friend murine leukemia virus.
    Matano T; Odawara T; Ohshima M; Yoshikura H; Iwamoto A
    J Virol; 1993 Apr; 67(4):2026-33. PubMed ID: 8445721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
    Katane M; Fujita R; Takao E; Kubo Y; Aoki Y; Amanuma H
    J Gene Med; 2004 Mar; 6(3):260-7. PubMed ID: 15026987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein.
    Chung M; Kizhatil K; Albritton LM; Gaulton GN
    J Virol; 1999 Nov; 73(11):9377-85. PubMed ID: 10516046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.
    Lavillette D; Boson B; Russell SJ; Cosset FL
    J Virol; 2001 Apr; 75(8):3685-95. PubMed ID: 11264358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic R-peptide of murine leukemia virus envelope protein negatively regulates its interaction with the cell surface receptor.
    Kubo Y; Izumida M; Togawa K; Zhang F; Hayashi H
    Virology; 2019 Jun; 532():82-87. PubMed ID: 31035110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins.
    Dragic T; Picard L; Alizon M
    J Virol; 1995 Feb; 69(2):1013-8. PubMed ID: 7815477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein.
    Lin AH; Kasahara N; Wu W; Stripecke R; Empig CL; Anderson WF; Cannon PM
    Hum Gene Ther; 2001 Mar; 12(4):323-32. PubMed ID: 11242525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of a third extracellular domain of an ecotropic receptor in Moloney murine leukemia virus infection.
    Bae EH; Park SH; Jung YT
    J Microbiol; 2006 Aug; 44(4):447-52. PubMed ID: 16953181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.
    Lavillette D; Ruggieri A; Boson B; Maurice M; Cosset FL
    J Virol; 2002 Oct; 76(19):9673-85. PubMed ID: 12208946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of lymphocyte cell lines coexpressing CD4 and wild-type or mutant HIV type 1 glycoproteins: implications for HIV type 1 Env-induced cell lysis.
    Krüger U; Pfeiffer T; Bosch V
    AIDS Res Hum Retroviruses; 1996 Jun; 12(9):783-92. PubMed ID: 8738430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion.
    Barnett AL; Cunningham JM
    J Virol; 2001 Oct; 75(19):9096-105. PubMed ID: 11533173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein.
    Johnston ER; Albritton LM; Radke K
    J Virol; 2002 Nov; 76(21):10861-72. PubMed ID: 12368329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion.
    Benedict CA; Tun RY; Rubinstein DB; Guillaume T; Cannon PM; Anderson WF
    Hum Gene Ther; 1999 Mar; 10(4):545-57. PubMed ID: 10094198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
    Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
    J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide.
    Yang C; Compans RW
    J Virol; 1996 Jan; 70(1):248-54. PubMed ID: 8523533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in a murine leukemia virus (MLV) receptor encoded by an alphavirus vector during passage in cells expressing the MLV envelope.
    Kazachkov Y; Long D; Wang C; Silver J
    Virology; 2000 Feb; 267(1):124-32. PubMed ID: 10648189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.